GSK Hepatitis B vaccine candidate containing HBsAg with adjuvants
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Hepatitis B vaccine candidate containing HBsAg with adjuvants, covering 2017-05-30 to 2017-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers [Phase 1]